Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Terminated 1Completed 1

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Other solid neoplasm 2Sarcoma 1Gastrointestinal 1

Conditions

Lung Neoplasms 8Carcinoma, Non-Small-Cell Lung 6Breast Neoplasms 6Sarcoma 5Unspecified Adult Solid Tumor, Protocol Specific 4Neoplasm Metastasis 4Colorectal Neoplasms 4Neoplasms 3Melanoma 3Colonic Neoplasms 3Thymoma 2Rectal Neoplasms 2Primary Myelofibrosis 2Pancreatic Neoplasms 2Myeloproliferative Disorders 2Multiple Myeloma 2Mesothelioma, Malignant 2Leukemia, Myelomonocytic, Chronic 2Esophageal Neoplasms 2Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Thrombocytosis 1Thrombocythemia, Essential 1Solid Tumor, Adult 1Small Cell Lung Carcinoma 1Sarcoma, Synovial 1Recurrence 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1

Interventions

Cisplatin 14Pemetrexed 11pembrolizumab 6Cyclophosphamide 6Radiotherapy 3Interleukin-2 3Gemcitabine 3sodium thiosulfate 2sargramostim 2defactinib 2aldesleukin 2Surgical Procedures, Operative 2SS1(dsFv)PE38 2Radiation 2Platinum 2Pharmaceutical Preparations 2Paclitaxel 2Nivolumab 2Drug Therapy 2Depsipeptides 2Decitabine 2Celecoxib 2Carboplatin 21,2-diaminocyclohexaneplatinum II citrate 2osimertinib 1incomplete Freund's adjuvant 1entinostat 1cabozantinib 1bemcentinib 1atezolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Mesothelioma, Malignant × Celecoxib × Clear all
NCT01143545 2020-03-03

Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural Mesotheliomas

National Institutes of Health Clinical Center (CC)

Phase 1 Terminated
10 enrolled
GastrointestinalOther solid neoplasmSarcomaThoracic

Mesothelioma, Malignant, Esophageal Neoplasms, Lung Neoplasms, Sarcoma, Thymoma

NCT00037817 2019-09-30

Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural Malignancies

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
34 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡